These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15088812)

  • 1. Is corporate influence good for medicine?
    Pontious JM
    J Okla State Med Assoc; 2004 Mar; 97(3):104. PubMed ID: 15088812
    [No Abstract]   [Full Text] [Related]  

  • 2. Taking money from the drug industry: the rules tighten.
    Elliott C
    Hastings Cent Rep; 2003; 33(4):6-7. PubMed ID: 12971053
    [No Abstract]   [Full Text] [Related]  

  • 3. Industry and medicine: conflicting interests and the power of money.
    Popovsky MA; Garcia N
    Transfusion; 2007 Jun; 47(6):1098-9. PubMed ID: 17524103
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comments on the editorial "The health sector and the perpetual murkiness in the relations between the medical profession and the drug industry" ].
    Oteo Ochoa LA
    Rev Calid Asist; 2009 Aug; 24(4):178-81. PubMed ID: 19647681
    [No Abstract]   [Full Text] [Related]  

  • 5. Conflict of interest in industry-sponsored drug development.
    Emanuel EJ
    Clin Adv Hematol Oncol; 2007 Apr; 5(4):265-7. PubMed ID: 17607285
    [No Abstract]   [Full Text] [Related]  

  • 6. Reject influence of pharmaceutical industry.
    McPartland JM
    J Am Osteopath Assoc; 2009 Dec; 109(12):655. PubMed ID: 20023226
    [No Abstract]   [Full Text] [Related]  

  • 7. Must an interest be a conflict?
    Lyles A
    Clin Ther; 2005 Mar; 27(3):344-5. PubMed ID: 15878388
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction between optometrists and industry representatives.
    Optometry; 2009 Mar; 80(3):149-53. PubMed ID: 19271358
    [No Abstract]   [Full Text] [Related]  

  • 9. The new drug war.
    Parloff R
    Fortune; 2004 Mar; 149(5):144-6, 148, 150 passim. PubMed ID: 15015428
    [No Abstract]   [Full Text] [Related]  

  • 10. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
    Lachin JM
    Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine.
    Finkel AG
    Headache; 2006; 46(7):1181-5. PubMed ID: 16866722
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethical issues arising from commercial sponsorship and from relationships with the pharmaceutical industry--report and recommendations of the Ethics Subcommittee of the International Headache Society.
    Steiner TJ
    Cephalalgia; 2008 Sep; 28 Suppl 3():1-25. PubMed ID: 18666973
    [No Abstract]   [Full Text] [Related]  

  • 13. Big pharma and American psychiatry.
    Sharfstein SS
    J Nerv Ment Dis; 2008 Apr; 196(4):265-6. PubMed ID: 18414119
    [No Abstract]   [Full Text] [Related]  

  • 14. Too friendly? Teaching hospitals revisit ties to pharmaceutical firms.
    Romano M
    Mod Healthc; 2003 Jul; 33(28):17. PubMed ID: 12884711
    [No Abstract]   [Full Text] [Related]  

  • 15. A quiz on "the ethics of accepting gifts from industry".
    Holm RP;
    S D Med; 2007 Mar; 60(3):117-8. PubMed ID: 17455581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unethical business practices in U.S. health care alarm physician leaders.
    Weber DO
    Physician Exec; 2005; 31(2):6-13. PubMed ID: 15844791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Academic medical centers and conflicts of interest.
    Angell M
    JAMA; 2006 Jun; 295(24):2848; author reply 2848-9. PubMed ID: 16804148
    [No Abstract]   [Full Text] [Related]  

  • 18. Ethical issues in the relationships involving medicine and industry.
    Thomas PS; Tan KS; Yates DH
    Intern Med J; 2005 Dec; 35(12):732. PubMed ID: 16313554
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethical issues in the relationships involving medicine and industry: evolving problems require evolving.
    Komesaroff P
    Intern Med J; 2005 Apr; 35(4):203-5. PubMed ID: 15836496
    [No Abstract]   [Full Text] [Related]  

  • 20. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Breen KJ
    Med J Aust; 2004 Apr; 180(8):409-10. PubMed ID: 15089732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.